South America BioChips Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Biochips are small laboratories which perform hundreds and thousands of biochemical reactions and decoding the genes in less time. Biochips are mostly used in the study of molecular biology. Biochips also known as biological microarray chips have transformed the healthcare industry to an extraordinary level and its applications have solved various health issues.

South America BiochipMarket Segments Size & Growth:

South AmericaBiochipMarket is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by a rise in usage of personalised medicine, rapid diagnosis and investments from the government. However, high cost and lack of awareness related to biological microarray hinder the growth of the South AmericaBiochipmarket.

South America Biochip Market Segments Share:

South AmericaBiochipMarket is categorised into by product type which consists of tissues biochip, protein microarrays, DNA microarrays, carbohydrate biochips, and lab-on-chip. DNA microarrays have the most extensive share because of increase in demand in the fields of proteomics and genomics. By application, South AmericaBiochip market is segmented as drug discovery, proteomics, cancer research, gene sequencing, and gene expression.  Among all drug discovery and gene expression are expected to have high growth rate during the forecast period 2018-2024, due to increase in demand for personalised medicine and genetic disorders.

By Geography, Brazil is dominating the South America biochip market, and the growth in South America is mainly attributed because of the increasing adoption of precision medicine and demand for rapid diagnostics.Furthermore, Argentina is witnessing the fastest growth during the forecast period, due to rising patients, healthcare awareness and government funding.

South America Biochip Market Segments Trends:

• In recent innovation at Stanford University School of Medicine have developed a way to manufacture cheap and reusable diagnostic device “Lab-on-Chip” in February 2017.
• In July 2017, Agilent Technologies Inc.acquired Cobalt Light Systems to expand opportunities in the pharmaceutical industry.

South America Biochip Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• Roche Holding A.G
• Biomerieux SA
• Illumina Corporate
• FLUIDIGM CORPORATION
• Cellix